Verbatim response from Perplexity
Wegovy is prescribed more easily by online clinics for weight loss because it is the only drug FDA-approved specifically for weight loss, whereas Ozempic is approved only for type 2 diabetes and must be prescribed off-label for weight loss.
Key Reasons Online Clinics Prefer Wegovy
| Factor | Wegovy | Ozempic |
|---|---|---|
| FDA Approval | Approved for chronic weight management in adults with BMI ≥30 (or ≥27 with comorbidities)[1][2][5] | Approved only for type 2 diabetes; weight loss is an off-label use[1][2][6] |
| Insurance Coverage | Most likely covered by insurers for weight loss since it is FDA-approved[8] | Less likely covered for weight loss due to off-label status[8] |
| Clinical Guidelines | Directly aligns with online clinic eligibility criteria for weight loss[2][6] | Clinics must justify off-label use, which can complicate approval[6][9] |
| Dose & Effectiveness | Higher dose (2.4 mg) → ~15% body weight loss in trials[3][10] | Lower dose (max 2 mg) → ~4–7% weight loss[3] |
Important Caveats
- Off-label Ozempic is still available: Some online clinics do prescribe Ozempic for weight loss if Wegovy is unavailable, too expensive, or if the patient has type 2 diabetes (making Ozempic the preferred choice)[2][9].
- Cost without insurance: Both are expensive without coverage (Ozempic ~$935/pen; Wegovy ~$1,349/package), but Wegovy may be more accessible through manufacturer support programs like NovoCare[4][6][8].
- Availability: Global shortages of semaglutide have occasionally limited Wegovy stock, temporarily pushing clinics toward Ozempic as an alternative[12].
Bottom line: If your primary goal is weight loss and you qualify (BMI ≥30 or ≥27 with health issues), Wegovy is the standard, easier-to-prescribe option for online clinics due to its regulatory approval and insurance alignment.